(Q33853038)

29 July 2017

1 reference

title

Thyrotropin-receptor antibodies in thyroid diseases: advances in detection techniques and clinical applications (English)

1 reference

29 July 2017

Gupta MK

1

1 reference

29 July 2017

publication date

1 March 2000

1 reference

29 July 2017

1 reference

29 July 2017

volume

293

1 reference

29 July 2017

issue

1-2

1 reference

29 July 2017

page(s)

1-29

1 reference

Molecular studies on thyrotropin (TSH) receptor and anti-TSH receptor antibodies

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Recent Progress in TSH Receptor Studies with a New Concept of "Autoimmune TSH Receptor Disease"

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

The thyrotropin receptor as a model to illustrate receptor and receptor antibody diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Recent progress in structure-function and molecular analyses of the pituitary/placental glycoprotein hormone receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Molecular cloning of the thyrotropin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Molecular cloning, sequence and functional expression of the cDNA for the human thyrotropin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Cloning, sequencing and expression of the human thyrotropin (TSH) receptor: evidence for binding of autoantibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Assignment of the human thyroid stimulating hormone receptor (TSHR) gene to chromosome 14q31.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Composite structure of the human thyrotropin receptor gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Norepinephrine and thyroid-stimulating hormone induce inositol phosphate accumulation in FRTL-5 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Thyroid-stimulating hormone stimulates increases in inositol phosphates as well as cyclic AMP in the FRTL-5 rat thyroid cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Norepinephrine and thyrotropin stimulation of iodide efflux in FRTL-5 thyroid cells involves metabolites of arachidonic acid and is associated with the iodination of thyroglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Thyroid stimulating immunoglobulins, like thyrotropin activate both the cyclic AMP and the PIP2 cascades in CHO cells expressing the TSH receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Receptor cross-talk can optimize assays for autoantibodies to the thyrotropin receptor: effect of phenylisopropyladenosine on adenosine 3',5'-monophosphate and inositol phosphate levels in rat FRTL-5 thyroid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Thyroperoxidase, but not the thyrotropin receptor, contains sequential epitopes recognized by autoantibodies in recombinant peptides expressed in the pUEX vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Thyrotropin-receptor-mediated diseases: a paradigm for receptor autoimmunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Identification of thyroid blocking antibodies and receptor epitopes in autoimmune hypothyroidism by affinity purification using synthetic TSH receptor peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

The extracellular domain of the TSH receptor has an immunogenic epitope reactive with Graves' IgG but unrelated to receptor function as well as determinants having different roles for high affinity TSH binding and the activity of thyroid-stimulating

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Identification of immunogenic regions in human thyrotropin receptor for immunoglobulin G of patients with Graves' disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Immunogenicity of a unique region of the human thyrotropin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Further characterization of a high affinity thyrotropin binding site on the rat thyrotropin receptor which is an epitope for blocking antibodies from idiopathic myxedema patients but not thyroid stimulating antibodies from Graves' patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Binding domains of stimulatory and inhibitory thyrotropin (TSH) receptor autoantibodies determined with chimeric TSH-lutropin/chorionic gonadotropin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Immunoglobulins from Graves' disease patients interact with different sites on TSH receptor/LH-CG receptor chimeras than either TSH or immunoglobulins from idiopathic myxedema patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Thyrotropin stimulation of the lutropin/choriogonadotropin receptor: different sites mediate agonist activity and high affinity binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Epitopes for thyroid-stimulating antibodies in Graves' sera: a possible link of heterogeneity to differences in response to antithyroid drug treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Further studies of amino acids (268-304) in thyrotropin (TSH)--lutropin/chorionic gonadotropin (LH/CG) receptor chimeras: cysteine-301 is important in TSH binding and receptor tertiary structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

The presence of an abnormal thyroid-stimulating hormone in the serum of some thyrotoxic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Delayed thyroid response to serum from thyrotoxic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Studies on the thyroid activator of hyperthyroidism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

CHARACTERIZATION OF THE LONG-ACTING THYROID STIMULATOR OF GRAVES' DISEASE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

New in vitro tests to detect the thyroid stimulator in sera from hyperthyroid patients by measuring colloid droplet formation and cyclic AMP in human thyroid slices.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

The thyrotrophin receptor in guinea-pig thyroid homogenate: interaction with the long-acting thyroid stimulator

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Thyroid-stimulating immunoglobulins in Graves' disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

27 Measurement of thyrotropin receptor antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

A receptor assay for the measurement of TSH receptor antibodies in unextracted serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Thyrotropin receptor antibodies: advances and importance of detection techniques in thyroid diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

A study of untreated Graves' patients with undetectable TSH binding inhibitor immunoglobulins and the effect of anti-thyroid drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Stable expression of the human TSH receptor in CHO cells and characterization of differentially expressing clones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Recombinant human thyrotropin (TSH) receptor in a radioreceptor assay for the measurement of TSH receptor autoantibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Binding assay for thyrotropin receptor autoantibodies using the recombinant receptor protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

The Human Thyrotropin (TSH) Receptor in a TSH Binding Inhibition Assay for TSH Receptor Autoantibodies1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Bioassay of TSH using dog thyroid cells in monolayer culture

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Thyroid-stimulating immunoglobulin bioassay using cultured human thyroid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Studies on the cyclic AMP response to thyroid stimulating immunoglobulin (TSI) and thyrotropin (TSH) in human thyroid cell monolayers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

A new in vitro assay for human thyroid stimulator using cultured thyroid cells: effect of sodium chloride on adenosine 3',5'-monophosphate increase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Clinical Experience with a Human Thyroid Cell Bioassary for Thyroid-Stimulating Immunoglobin *

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

A sensitive and practical assay for thyroid-stimulating antibodies using crude immunoglobulin fractions precipitated with polyethylene glycol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Culture of hormone-dependent functional epithelial cells from rat thyroids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Characterization of the Optimal Stimulatory Effects of Graves’ Monoclonal and Serum Immunoglobulin G on Adenosine 3′,5′-Monophosphate Production in FRTL-5 Thyroid Cells: A Potential Clinical Assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Graves’ IgG stimulation of continuously cultured rat thyroid cells: a sensitive and potentially useful clinical assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Characterization of thyroid-stimulating immunoglobulin-induced cyclic AMP accumulation in the rat thyroid cell strain FRTL-5: potentiation by forskolin and calibration against reference preparations of thyrotrophin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Thyroid-stimulating antibody assay using a human thyrotropin receptor transfected cell line: relationship to clinical features of graves' disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Clinical utility of thyrotropin-receptor antibody assays: comparison of radioreceptor and bioassay methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Use of the recombinant human thyrotropin receptor (TSH-R) expressed in mammalian cell lines to assay TSH-R autoantibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Detection and Properties of TSH-Binding Inhibitor Immunoglobulins in Patients with Graves’ Disease and Hashimoto’s Thyroiditis*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Primary myxedema with thyrotrophin-binding inhibitor immunoglobulins. Clinical and laboratory findings in 15 patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Blocking type antithyrotropin receptor antibody in patients with nongoitrous hypothyroidism: its incidence and characteristics of action.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Detection and characterization of autoantibodies blocking the TSH-dependent cAMP production using FRTL-5 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Inhibition of Thyrotropin-Induced Adenosine 3′5′-Monophosphate Increase by Immunoglobulins from Patients with Primary Myxedema*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Evidence for thyrotropin (TSH)-blocking activity in goitrous Hashimoto's thyroiditis with assays measuring inhibition of TSH receptor binding and TSH-stimulated thyroid adenosine 3',5'-monophosphate responses/cell growth by immunoglobulins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Inhibition of thyrotropin-stimulated iodide uptake in FRTL-5 thyroid cells by crude immunoglobulin fractions from patients with goitrous and atrophic autoimmune thyroiditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Transient Neonatal Hypothyroidism Due to Maternal Immunoglobulins that Inhibit Thyrotropin-Binding and Post-Receptor Processes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Blocking activity to action of thyroid stimulating hormone in serum from patients with primary hypothyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Inhibition of thyrotropin-induced growth of rat thyroid cells, FRTL-5, by immunoglobulin G from patients with primary myxedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Thyroid growth-blocking antibodies in primary myxoedema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Familial Neonatal Transient Hypothyroidism Due to Maternal TSH-Binding Inhibitor Immunoglobulins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Detection of antibodies blocking thyrotropin effect using Chinese hamster ovary cells transfected with the cloned human TSH receptor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Further studies on thyroid growth-stimulating immunoglobulins in euthyroid nonendemic goiter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Antibodies that promote thyroid growth. A distinct population of thyroid-stimulating autoantibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Thyroid growth-stimulating immunoglobulins in goitrous disease: relationship to thyroid-stimulating immunoglobulins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Assays for thyroid growth immunoglobulins and their clinical implications: methods, concepts, and misconceptions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Chromatographically purified immunoglobulin G of endemic and sporadic goiter patients stimulates FRTL5 cell growth in a mitotic arrest assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Do thyroid growth-promoting immunoglobulins exist?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

A new chemiluminescent assay for the rapid detection of thyroid stimulating antibodies in Graves' disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Epitope heterogeneity of thyrotropin receptor-blocking antibodies in Graves' patients as detected with wild-type versus chimeric thyrotropin receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Critical relationship between autoantibody recognition and thyrotropin receptor maturation as reflected in the acquisition of complex carbohydrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Molecular cloning of a human thyrotropin receptor cDNA fragment. Use of highly degenerate, inosine containing primers derived from aligned amino acid sequences of a homologous family of glycoprotein hormone receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Heterogeneity of the Graves' Immunoglobulins Directed toward the Thyrotropin Receptor-Adenylate Cyclase System*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

The assay of Graves' immunoglobulins: a comparison of different methods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Correlation between Thyroid Stimulators and 3,5,3′-Triiodothyronine Suppressibility in Patients during Treatment for Hyperthyroidism with Thionamide Drugs:Comparison of Assays by Thyroid-Stimulating and Thyrotropin-Displacing Activities*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Comparison between thyroid stimulating and tsh-binding inhibiting immunoglobulins of Graves' disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Correlation between Thyrotropin-Displacing Activity and Human Thyroid-Stimulating Activity by Immunoglobulins from Patients with Graves' Disease and Other Thyroid Disorders*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Monoclonal antibodies to the thyrotropin receptor: the identification of blocking and stimulating antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Characterization of monoclonal antibodies derived from lymphocytes from Graves' disease patients in a cytochemical bioassay for thyroid stimulators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Heterogeneity of Graves' immunoglobulin G: comparison of thyrotropin receptor antibodies in serum and in culture supernatants of lymphocytes transformed by Epstein-Barr virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Thyroid-stimulating antibodies in sera from patients with Graves' disease are heterogeneous in epitope recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Subtypes of anti-TSH receptor antibodies classified by various assays using CHO cells expressing wild-type or chimeric human TSH receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Thyroid controversy--stimulating antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Role of thyrotropin receptor antibodies in the development of hyperthyroidism: follow-up studies on nine patients with Graves' disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

THYROID BINDING ANTIBODIES AND OTHER IMMUNOLOGICAL ABNORMALITIES IN PATIENTS WITH GRAVES’OPHTHALMOPATHY: EFFECT OF TREATMENT WITH CYCLOPHOSPHAMIDE

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Thyrotropin Displacement Activity of Serum Immunoglobulins from Patients with Graves’ Disease*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Ophthalmopathy in early thyrotoxicosis--relationship to thyroid receptor antibodies and effects of treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Correlation of orbital computed tomography and antibodies in patients with hyperthyroid Graves' disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

The management of hyperthyroidism due to Graves' disease in Japan in 1988. The Japan Thyroid Association

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Value of thyroid-stimulating-antibody determinations in predicting short-term thyrotoxic relapse in Graves' disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Prognostic value of thyrotrophin binding inhibiting immunoglobulins (TBII) in longterm antithyroid treatment, 131I therapy given in combination with carbimazole and in euthyroid ophthalmopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Thyroid stimulating antibodies (TSAb) in patients with Graves' disease undergoing antithyroid drug treatment: indicators of activity of disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Prediction of relapse in hyperthyroid Graves' disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Changes in thyroid-stimulating antibody activity in Graves' disease treated with antithyroid drug and its relationship to relapse: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Thyroid hypoechogenicity after methimazole withdrawal in Graves' disease: a useful index for predicting recurrence?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

The mechanism of spontaneous hypothyroidism in patients with Graves' disease after antithyroid drug treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Treatment of Graves' disease and the course of ophthalmopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Relation between therapy for hyperthyroidism and the course of Graves' ophthalmopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Occurrence of Ophthalmopathy after Treatment for Graves' Hyperthyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Effects of radioiodine on thyrotrophin binding inhibiting immunoglobulins in Graves' disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

A Prospective Study of the Changes in Thyrotropin Binding Inhibitory Immunoglobulins in Graves' Disease Treated by Subtotal Thyroidectomy or Radioactive Iodine*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Effect of radioiodine on stimulatory activity of Graves' immunoglobulins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Production of non-stimulatory immunoglobulins that inhibit TSH binding in Graves' disease after radioiodine administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Specific Effects of Radioiodine Treatment on TSAb and TBAb Levels in Patients with Graves' Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Pathophysiological role of thyroid blocking antibody in patients with primary hypothyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Characterization of TSH antagonist activity in the serum of patients with thyroid disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Low prevalence of thyrotropin receptor antibody in primary hypothyroidism in Japan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Incidence of antibodies blocking thyrotropin effect in vitro in patients with euthyroid or hypothyroid autoimmune thyroiditis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Pregnancy-Associated Changes in the Thyroid-Stimulating Antibody of Graves’ Disease and the Relationship to Neonatal Hyperthyroidism*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Maternal thyroid-blocking immunoglobulins in congenital hypothyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Maternal TSH-receptor antibodies and TSH antibodies in screening for congenital hypothyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Thyrotropin (TSH) receptor and adenylate cyclase activity in human thyroid tumors: absence of high affinity receptor and loss of TSH responsiveness in undifferentiated thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

The role of thyroid-stimulating antibodies of Graves' disease in differentiated thyroid cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Thyroid carcinoma in thyrotoxic patients treated by surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Incidence of thyroid carcinoma in Graves' disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

Increased aggressiveness of thyroid cancer in patients with Graves' disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-8981%2899%2900235-1

10.1016/S0009-8981(99)00235-1

7 January 2021

Identifiers

DOI

1 reference

release_6y3siaar4bdbxkvhidikn7cfn4

29 July 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/6y3siaar4bdbxkvhidikn7cfn4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference